Skip to content
Home/Companies/Healthcare/Shenzhen Salubris Pharmaceutical Co., Ltd
SS

Shenzhen Salubris Pharmaceutical Co., Ltd

Healthcare·China·Exited

Shenzhen Salubris Pharmaceutical Co., Ltd is a healthcare company, headquartered in China.

Entry
–
Hold
–
Exit
–
Est. EV
–

Who owns Shenzhen Salubris Pharmaceutical Co., Ltd?

Shenzhen Salubris Pharmaceutical Co., Ltd was owned by The Carlyle Group through Carlyle Sub-Saharan Africa Fund (2018 vintage).

Hand-verified · updated 2026-04-21

The Carlyle Group
Investor
The Carlyle Group
Carlyle Sub-Saharan Africa Fund · 2018 · Buyout

Key facts

HQChina
SectorHealthcare
Exit Type
–
Buyer
–
MOIC
–
Exit Year
–

More from Carlyle Sub-Saharan Africa Fund

Other portfolio companies in the same fund.

A Twosome Place
Active
ConsumerUS
Abacus Pharmaceuticals
Active
HealthcareUS
Accolade Wines
Active
ConsumerAustralia
Amecor
Exited 2024
TMTUS
to
Amrod
Exited 2023
ConsumerUS
to
CMC Networks
Active
TMTSouth Africa

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
4ways
Active
ECI PartnersUK
A Place for Mom
Active
Silver LakeUS
Abcam (exited)
Active
EMV CapitalUK
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings